Search results
2020 tercatat di Indonesia ada 4.557 kasus positif dan juga dilaporkan 380 orang sembuh serta 399 orang lainnya dinyatakan meninggal. Menurut data tersebut, berarti masih ada 3.778 pasien positif Covid-19 atau sekitar 82,9 persen, serta persentase Case Fatality Rate (CFR) atau angka kematian mencapai 8,75 persen.
AbstrakCOVID-19 telah menjadi pandemik di Indonesia sejak ditemukannya kasus pertama pada tanggal 2 Maret 2020 di Depok. Peningkatan kasus perhari semakin tinggi sejak akhir Agustus 2020 yang mencapai lebih dari 2000 kasus per hari. Sistem kesehatan di Indonesia perlu ditingkatkan dalam hal kapasita ….
23 maj 2022 · As an archipelagic country, Indonesia has various physical and social environments, which implies that each region has a different response to the pandemic. This study aims to analyze the spatial differentiation of COVID-19 in Indonesia and its interactions with socioenvironmental factors.
2 sie 2020 · The Covid-19 virus has spread across the world with alarming speed, infecting millions and causing economic disruption on an unprecedented scale. In this survey, we examine the impact of the outbreak on the Indonesian economy, as well as the government’s response to the public health crisis and its provisions for the emerging economic crisis.
The COVID-19 pandemic situation in Indonesia, Malaysia and Taiwan in 2021 is significantly different from 2020. Malaysia had the highest COVID-19 vaccination coverage (79.4%), followed by Taiwan (78.5%) and Indonesia (58.3%).
This review describes the challenges of COVID-19 management in Indonesia as a populous, socially and culturally diverse, and archipelagic country. It aims to provide multidisciplinary perspectives for a safe, evidence-based, and productive new normal as well as a comprehensive and integrated actionable policy for COVID-19 control.
12 maj 2022 · As of August, 2021, Indonesia had 3,892,479 confirmed COVID-19 cases, with 120,013 deaths . In the early phase of COVID-19 pandemic, besides the vast territory, Indonesia was also challenged with limited laboratory infrastructure and capacity for COVID-19 diagnosis.
